Emma Louise Robinson, PhD

Tomorrow, I start a new role as Sr. Manager in Scientific Communications in the THV team at @EdwardsLifesci. 👩‍💼👩‍💻 @EdwardsLifesci is a global leader in interventions for structural heart disease, critical care and surgical monitoring. I am so excited to join this cause! #scicomm

My lab is seeking a postdoc fellow with strong molecular biology research background. We are focused on transcriptional condensates and RNA binding proteins in the cardiovascular system.

How does the novel Sapien M3 device perform in TMVR for patients ineligible for other interventions? Watch David Daniels discuss the 1-year data from the ENCIRCLE trial at #TCT2025, and read more from TCTMD: tctmd.com/news/encircle-…

PARTNER 3: transcatheter or surgical aortic-valve replacement in low-risk patients at 7 years 🔗pcronline.com/PCR-Publicatio… @DrBelluschi and @sbrugaletta review ✍️ the results of this trial that showed that at 7 years, low-risk patients affected by severe symptomatic aortic valve stenosis 1:1 randomly treated by SAPIEN 3 TAVI or surgery showed similar clinical outcomes and late valve durability. #interventionalcardiology #TAVI #TAVR

This week, I graduated from the Amplify program @EdwardsLifesci, a 16-week program of self-led leadership and development trainings combined with small group peer-to-peer support. 🫶🏻 Grateful for this opportunity to learn and make new connections throughout the company.🙏🏼

Our BCVS Chair Dr. Kontaridis reflected on the invaluable support of the @AHAScience encouraging the next generation of scientists to take part in this vibrant and collaborative community. #AHA100 #BCVS #AHA2025 @DrHelenECollin1

‼️Exciting Event‼️ The @ECI_ISHR committee is hosting a Winter Webinar Symposia for pre- and post-doctoral trainees. Selected abstracts will present oral talks with the opportunity to win Travel Awards to the 2026 ISHR-NAS conference. See below for more details and submit now!

Please help to repost ⏰⏰⏰ The Tong Lab @UTSWMedCenter is recruiting a postdoctoral fellow to join us in studying the molecular mechanisms of HFpEF and atrial fibrillation. Prior experience in cardiac pathophysiology, immunology and bioinformatics is preferred but not required. labs.utsouthwestern.edu/tong-lab utsouthwestern.edu/research/postd…

Are you looking for a PhD position and want to spend your summers in the Rocky Mountains? My lab @CUDenver is looking for 1 PhD student to work on a NSF-funded project to study elevational range shifts in Colorado! Apply by Nov 1! Details here docs.google.com/document/d/1Zy…

🎉 Congratulations to Dr. Doug Tilley on his promotion to Associate Dean of Faculty Affairs at LKSOM! We’re excited to see his continued leadership in shaping the future of our faculty and advancing academic excellence. 👏

As a Guest Editor for @JoVEJournal, Im organising a Collection titled “Cellular Cross-Talk in the Heart: Experimental Approaches to Cardiac Cell Interactions.” Interested in contributing? Please submit your proposal here: app.jove.com/methods-collec…

I am grateful to be involved as a volunteer ‘Guide’ in the UT system Career Exploration Network, providing personal and professional development advice for PhD students and postdoctoral trainees 'Seekers'. 👩‍🎓🧑‍🎓🤝 Learn more about the program here: youtu.be/CmGpFLdXVcw

I had a terrific, highly informative time at the @crfheart #NYValves 2025, held in the🩵of NYC. Hot topics included timing of aortic valve replacement in patients living with aortic stenosis without symptoms and latest innovations in structural heart disease. 🩺 🫶

Big updates ahead!💡🫀 Catch late-breaking trial results at #NYValves2025. Get fresh insights on EARLY TAVR, treatment disparities, redo TAVR, new valve technologies, and more! @djc795 @SammyElmariahMD @suzannejbaron @ShinFukuharaMD #CardioResearch #CardioEd #CardioX

🗞️Heart failure and obesity: exploring translational insights and therapeutic strategies. 👉Read the new scientific statement from #HFA_ESC ow.ly/sZGr50W7y8G @EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd @GianluSava

Latest EARLY TAVR data: Cardiac damage was frequent in pts enrolled in the trial of TAVI in asymptomatic AS, with those treated preemptively more likely to show an improvement in their stage of clinical damage @PhilGenereuxMD #EuroPCR

🎥Hotline #TAVI🔥 at #EuroPCR: Philippe Genereux highlighted findings from the EARLY #TAVR trial, which investigated the incidence, progression, and clinical impact of cardiac damage in patients with asymptomatic severe aortic stenosis. @ABeneduceMD asked him to break down the key insights⬇️

Last week to register for the 2025 @AmwaRmc Spring conference - Registration closes 5/22! When: Saturday, June 7 9:00am - 5:00pm MDT Where:  Hyatt Regency Aurora-Denver Conference, Colorado  Register here: eventbrite.com/e/132584285466… Registration is $15 for members!

🚨 Calling all #EarlyCareer scientists! 🔬 Want to dive into cutting-edge –omics research? Join top experts from @UCSanDiego, @UWMadison, @UIowa, @CedarsSinai + more! 🗓️ Wed, May 7 | 3–4:15pm EST 🎟️ Free with AHA membership 👉 bit.ly/BCVSEC #CardioTwitter @AHAScience

Ever want to incorporate -omics techniques into your own research?!?! Tune in for a great AHA @BCVSearlyCareer webinar on this topic. Learn how these cutting edge techniques are transforming our understanding of cardiovascular biology! #cardiotwitter, @AHAScience @ECI_ISHR

Some very exciting news! The FDA has approved TAVR with the @EdwardsLifesci SAPIEN 3 platform to treat patients with asymptomatic, severe aortic stenosis in the U.S. Wonderful news for patients and their loved ones. #lifeisnow #tavr 🫀🙏ir.edwards.com/news/news-deta…